Pharmaceuticals Italy

Italy Veterinary Drugs Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Italy Veterinary Drugs Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Italy · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $966.8 Mn Placeholder estimate
Estimate 2025 $1.03 Bn 2.4% of the global market
Projected 2034 $1.81 Bn 76.3% Adds $785.2 Mn over 9 forecast years
CAGR 2025–2034 6.5% Faster than 38% of 183 Pharmaceuticals markets here
Key players 6 +1
  • Italy is 2.37% of the global market.
  • In Europe, the largest is Germany at $1.34 Bn.
  • Fastest growing: Russia at 7.1% a year.
  • Italy ranks 3rd of 13 by size in Europe.

Market size projection

Italy

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$785.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Veterinary Drugs Market market size by year, Italy
YearMarket sizeChange that yearSince 2025
2024 (estimate) $966.8 Mn — —
2025 (base) $1.03 Bn +$62.8 Mn —
2026 (forecast) $1.10 Bn +$66.9 Mn +6.5%
2027 (forecast) $1.17 Bn +$71.3 Mn +13.4%
2028 (forecast) $1.24 Bn +$75.9 Mn +20.8%
2029 (forecast) $1.32 Bn +$80.8 Mn +28.6%
2030 (forecast) $1.41 Bn +$86.1 Mn +37%
2031 (forecast) $1.50 Bn +$91.7 Mn +45.9%
2032 (forecast) $1.60 Bn +$97.7 Mn +55.4%
2033 (forecast) $1.70 Bn +$104.0 Mn +65.5%
2034 (forecast) $1.81 Bn +$110.8 Mn +76.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Italy Veterinary Drugs Market Analysis at a glance
Market size, 2025$1.03 Bn placeholder estimate
Forecast, 2034$1.81 Bn placeholder estimate
Growth (CAGR), 2025–20346.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and animal (see all)
Key playersZoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and 1 more (see all)
Regulator in ItalyAIFASource: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Italy Veterinary Drugs Market Analysis Executive Summary

Veterinary drugs are the medicines given to pets and farm animals to treat or prevent disease and pain.

Key segments of the veterinary drugs market include product (Anti-Infectives, Anti-Parasitics and Anti-Inflammatories) and animal (Dogs, Cats and Cattle).

Bar chart: Italy Veterinary Drugs market size, 2024–2034, placeholder estimates. $966.8 Mn in 2024, $1.03 Bn in 2025 and $1.81 Bn in 2034, 6.5% CAGR.
Italy Veterinary Drugs market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Italy Veterinary Drugs Market Dynamics

Market Growth Drivers

More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.

Opportunity

Long-acting treatments, tests that find disease early and growing pet spending in emerging countries give the veterinary drugs market room to grow.

Market Restraints

Rules on antibiotic use in farm animals, high drug prices for pet owners and shortages of vets in rural areas hold back the veterinary drugs market.

Competitive Landscape for Veterinary Drugs Market in Italy

The veterinary drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Veterinary Drugs Market in Italy

Veterinary Drugs in Italy: rules and payment

Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement.⁠[1] The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for.⁠[2]

[1] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[2] Italian Ministry of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for veterinary drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Italy.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Veterinary Drugs right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Veterinary Drugs in context

Italy compared

  • Health spending per person: 3,398 US$ per person (2024). World: 1,317 US$ per person (2023). 9th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 4.19 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 7th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 25.1% of people (2025). World: 10.4% of people (2025). Highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Veterinary Drugs market in Italy?
Placeholder estimate: about $1.03 Bn in 2025, rising to about $1.81 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Veterinary Drugs market in Italy growing?
Placeholder estimate: about 6.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Veterinary Drugs market report cover?
The report splits the market by product (Anti-Infectives, Anti-Parasitics, Anti-Inflammatories, Vaccines and more) and animal (Dogs, Cats, Cattle, Poultry and more).
Who are the key players in the Veterinary Drugs market?
Key players include Zoetis, Inc, Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva Sante Animale and Virbac.
What is driving the Veterinary Drugs market?
More pet ownership, spending on pet care, rising demand for meat and milk, and concern about animal disease are driving the veterinary drugs market.
Who regulates Veterinary Drugs in Italy?
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by AIFA, the Italian Medicines Agency, which also negotiates prices and reimbursement. Source: Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
How is healthcare paid for in Italy?
The National Health Service (SSN), run by the regions, gives universal cover, and AIFA decides which medicines it pays for. Source: Italian Ministry of Health. Checked 14 Nov 2026.
How much research is published on Veterinary Drugs?
PubMed lists 556 papers on Veterinary Drugs added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 21 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Italy

See all

Related on animal health

See the topic